Clinical Trials Logo

Filter by:
NCT ID: NCT02096809 Completed - Clinical trials for Hearing Loss - Conductive

Stability of the Cochlear Baha BI300/BA400 Implant System Loaded From 1 Week Post-surgery

Start date: March 2014
Phase: N/A
Study type: Interventional

Objectives - To evaluate the safety of processor loading of the Cochlear BI300/BA400 implant system 1 week after implantation - To evaluate the short term soft tissue healing and the long term skin reaction, with the new Cochlear BI300/BA400 implant system using the linear incision without subcutaneous tissue reduction. - To produce reference data regarding the stability of the BI300/BA400 implant system. Study design: Prospective cohort study. Patients: 24 adults with anticipated normal skin and bone quality eligible for bone anchored implant surgery. Intervention: Loading of the sound processor one week after surgery Main outcome measures: Implant stability, soft tissue reaction, skin overgrowth, pain and numbness will be assessed. It is hypothesized that implant loading can be performed one week after surgery without any changes in implant stability, soft tissue reaction, skin overgrowth, pain or numbness around implant.

NCT ID: NCT02094183 Completed - Obesity Clinical Trials

The Interaction Between Appetite Hormones

Start date: September 2011
Phase: N/A
Study type: Interventional

Glucagon Like Peptide (GLP) -1 affects metabolic response corrected for weight change

NCT ID: NCT02094079 Completed - Hypothyroidism Clinical Trials

Monitoring and Evaluation of the Levothyroxin Replacement Therapy in Pregnant Women With Hypothyroidism

Start date: March 2014
Phase: N/A
Study type: Observational

The aim of the study was to evaluate the clinical control program in patients with hypothyroidism during pregnancy (suggested in resent guidelines). Is it possible by monitoring the patients every 4. week during pregnancy to keep the thyroid function parameters within the recommended range? A retrospective study of consecutive pregnant women with hypothyroidism followed at the outpatient clinic at the Endocrinology Unit, Herlev Hospital, Denmark during 2012. Patients selected through electronic medical system. Blood tests for the The hormone levels drawn from the laboratory of Clinical Biochemical Department, Herlev Hospital

NCT ID: NCT02094040 Completed - Frailty Clinical Trials

Municipality-based Post-discharge Follow-up Visits

Start date: February 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether discharge follow-up visit by primary physician and community-based nurse affects the risk of early re-hospitalisation among high risk older people discharged from a medical ward.

NCT ID: NCT02093585 Completed - HIV Clinical Trials

Tenofovir Abacavir Platelet Activation Study

TAPAS
Start date: January 2014
Phase: Phase 4
Study type: Interventional

Some but not all observational studies have found that current exposure to abacavir is associated with increased risk of cardiovascular events such as myocardial infarction, stroke and cardiovascular death. This study aim to investigate possible adverse effect of abacavir on platelet reactivity, coagulation and endothelial activation in HIV-1 infected patients. The study is an open-labeled cross-over trial, where patients receiving antiretroviral therapy containing abacavir switch treatment to a regimen containing tenofovir and vice versa for a period of 90 days.

NCT ID: NCT02093351 Completed - Solid Tumours Clinical Trials

To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer

Start date: September 1, 2014
Phase: Phase 1
Study type: Interventional

This is an open-label 2-part Phase I study in patients with advanced solid tumours. Part A of the study (mandatory) will assess the effect of olaparib on the pharmacokinetics (PK) of anastrozole, letrozole and tamoxifen and vice versa; Part B will allow patients (if eligible) continued access to olaparib after the PK phase and will provide additional safety data.

NCT ID: NCT02093312 Completed - Lung Cancer Clinical Trials

Meals on Wheels, the Effect of a Home Food-delivery Service for Cancer Patients

RUMLE
Start date: March 2014
Phase: N/A
Study type: Interventional

The overall objective of the study is to investigate the effect of energy- and protein enriched home delivered meals vs. habitual diet in malnourished patients suffering from cancer on various endpoints.

NCT ID: NCT02092896 Completed - Diabetes Clinical Trials

Liraglutide as add-on to Insulin in Type 1 Diabetes

T1DMLIRA
Start date: March 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to: Part 1: To investigate how 12 weeks treatment with liraglutide affects glycemic control in poorly controlled patients and how the treatment affects gastric emptying rate during hypoglycemia. Part 2: To investigate how 12 weeks treatment of type 1 diabetic patients with liraglutide affects counterregulatory hormones and cognitive performance during hypoglycemia.

NCT ID: NCT02092818 Completed - Clinical trials for Hypertension, Pulmonary

EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension

EXPERT
Start date: May 31, 2014
Phase:
Study type: Observational

In accordance with the regulatory guidance this registry has been designed to collect information about the long-term safety of Adempas in real clinical practice outside the regulated environment of a controlled clinical study.

NCT ID: NCT02091830 Completed - Knee Osteoarthritis Clinical Trials

Non-surgical Treatment of Knee Osteoarthritis - a Comparison of Effects in 2200 Patients

Start date: January 2013
Phase: N/A
Study type: Observational

The purpose of this study is to assess whether radiographic osteoarthritis severity (OA; Kellgren-Lawrence scale) is associated with self-reported improvement in pain after non-surgical treatments (physiotherapy, pain killers, injection, other treatments). The hypothesis is that radiographic OA severity is inversely associated with self-reported improvement.